Vitamin D Treatment for Crohn´s Disease
Remission Keeping and Remission Inducing Effect by Vitamin-D in Crohns Disease, and in Vitro Vitamin-D Mediated T-Cell Immunomodulation
1 other identifier
interventional
110
1 country
4
Brief Summary
The purpose of this study is to examine whether vitamin D treatment is effective in Crohn's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Sep 2005
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2005
CompletedFirst Posted
Study publicly available on registry
August 19, 2005
CompletedStudy Start
First participant enrolled
September 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2008
CompletedApril 13, 2007
April 1, 2007
August 18, 2005
April 12, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relapse rate within 1 year treatment; CDAI>220
Interventions
Eligibility Criteria
You may qualify if:
- Crohn's disease
- Inactive Crohn's disease for at least 4 weeks
- Crohn's Disease Activity Index (CDAI) \< 150
- C-reactive protein within normal range
- Serum albumin within normal range
You may not qualify if:
- Hypercalcemia
- Short bowel syndrome
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Aarhus University Hospital, Department V
Aarhus, 8000, Denmark
Hospital of Horsens
Horsens, 8700, Denmark
Hospital of Randers
Randers, 8900, Denmark
Hospital of Silkeborg
Silkeborg, 8600, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens F. Dahlerup, MD, DrMedSc
Aarhus University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 18, 2005
First Posted
August 19, 2005
Study Start
September 1, 2005
Study Completion
February 1, 2008
Last Updated
April 13, 2007
Record last verified: 2007-04